Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Feb;7(2):e007533.
doi: 10.1136/bmjgh-2021-007533.

Clinical research on COVID-19: perceptions and barriers to participation in The Gambia

Brahima Amara Diallo  1 , Effua Usuf  2 , Omar Ceesay  2 , Umberto D'Alessandro  2 , Anna Roca  2 , Melisa Martinez-Alvarez  2
Affiliations

Clinical research on COVID-19: perceptions and barriers to participation in The Gambia

Brahima Amara Diallo et al. BMJ Glob Health. 2022 Feb.

Abstract

Introduction: The need to rapidly identify safe and efficacious drug therapies for COVID-19 has resulted in the implementation of multiple clinical trials investigating potential treatment options. These are being undertaken in an unprecedented research environment and at a higher speed than ever before. It is unclear how West African communities perceive such activities and how such perceptions influence participation in COVID-19 clinical trials. This qualitative study was conducted to assess the level of acceptability of a clinical trial on the prevention and treatment of COVID-19 in The Gambia and identify strategies to better engage communities in participating in such a trial.

Methods: Data were collected using digitally recorded semistructured interviews (SSIs) and focus group discussions (FGDs) in Brikama and Kanifing local government areas. These are two of the most densely populated administrative subdivisions in The Gambia, where the clinical trial was to be implemented by the MRC Unit The Gambia. 26 men and 22 women aged between 19 and 70 years, with diverse socioeconomic profiles, participated in 8 FGDs (n=36) and 12 SSIs (n=12). Thematic analysis was used to analyse the data.

Results: Fear of stigmatisation of patients with COVID-19 was a recurring theme in most FGDs and SSIs, with detrimental effects on willingness to accept COVID-19 testing and home visits to follow up patients with COVID-19 and their household contacts. Preserving the privacy of individuals enrolled in the study was key to potentially increase trial participation. Trust in the implementing institution and its acknowledged expertise were facilitators to accepting the administration of investigational products to sick individuals and their close contacts.

Conclusion: COVID-19 is a stigmatising disease. Developing a research-participant collaboration through an ongoing engagement with community members is crucial to a successful enrolment in COVID-19 clinical trials. Trust and acknowledged expertise of the implementing institution are key facilitators to foster such collaboration.

Keywords: COVID-19; health education and promotion; health systems evaluation; prevention strategies; public health.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Map of study locations. Study sites are highlighted in blue. The map was designed using Quantum Geographic Information System (QGIS), a free and open-source Geographic Information System software.
See this image and copyright information in PMC

References

    1. WHO . Who coronavirus (COVID-19) Dashboard, 2021. Available: https://covid19.who.int/ [Accessed 17 Sep 2021].
    1. Hu B, Guo H, Zhou P, et al. . Characteristics of SARS-CoV-2 and COVID-19. Nat Rev Microbiol 2021;19:141–54. 10.1038/s41579-020-00459-7 - DOI - PMC - PubMed
    1. Medicine USNLo . ClinicalTrial.Gov. Recruiting Studies, COVID-19 [Web]. US: National Library of Medicine, 2021. Available: https://clinicaltrials.gov/ct2/results/map?recrs=a&cond=COVID-19&map= [Accessed 17 Sep 2021].
    1. COVID-19 Vaccination . Latest updates from Africa CDC on progress made in COVID-19 vaccinations on the continent. [Internet]. Centre for Disease Control and Prevention, 2021. Available: https://africacdc.org/covid-19-vaccination/ [Accessed 17 Sep 2021].
    1. WHO . “Guidelines for Good Clinical Practice (GCP) for Trials on Pharmaceutical Products”[UNAIDS Meeting-Ethical Considerations in Preventative Vaccine Trials Against HIV/AIDS. 1998: Geneva, Switzerland: World Health Organization, 1995.

Publication types